文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

SARS-CoV-2血清学与自我报告感染——美国国家健康与营养调查,2021年8月至2022年5月

SARS-CoV-2 Serology and Self-Reported Infection Among Adults - National Health and Nutrition Examination Survey, United States, August 2021-May 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-12-02

美国国家健康与营养调查(NHANES)2021-2022年初步结果显示,41.6%的成人血清学提示既往感染,其中43.7%报告从未患COVID-19(非西班牙裔黑人或非洲裔美国成人中为57.1%),可能代表无症状感染;25.5%血清学提示既往感染的成人报告从未接种COVID-19疫苗。未接种疫苗情况下的血清阳性率在年轻成人和黑人成人中更高,反映这些群体观察到的较低疫苗接种率。

要点

  • 41.6%的成人血清学提示既往SARS-CoV-2感染。
  • 43.7%的血清阳性成人报告从未患COVID-19,黑人成人中为57.1%。
  • 25.5%的血清阳性成人报告从未接种COVID-19疫苗。

核心结论

  • NHANES数据可用于更好地量化无症状SARS-CoV-2感染患病率和通过感染而非疫苗接种获得的血清阳性。
  • 未接种疫苗情况下的血清阳性率在年轻成人和黑人成人中更高,反映这些群体观察到的较低疫苗接种率。
  • 鉴于观察到的SARS-CoV-2感染和COVID-19疫苗接种差异,这些发现引发健康公平担忧。
  • NHANES 2021-2022结果可指导当前努力,以实现COVID-19基础免疫系列和加强针覆盖的疫苗公平。

研究设计与样本

  • 美国国家健康与营养调查(NHANES)收集一般美国平民样本的SARS-CoV-2血清学数据。
  • NHANES收集自我报告的COVID-19疫苗接种和疾病史,其统计抽样设计不基于医疗保健可及性或献血。
  • CDC COVID-19监测系统使用商业实验室献血者数据的国家便利样本监测SARS-CoV-2抗体流行率。

主要发现

  • NHANES 2021-2022初步结果显示,41.6%的≥18岁成人血清学提示既往感染。
  • 43.7%的血清学提示既往感染成人报告从未患COVID-19。
  • 57.1%的血清学提示既往感染非西班牙裔黑人或非洲裔美国成人报告从未患COVID-19。
  • 25.5%的血清学提示既往感染成人报告从未接种COVID-19疫苗。
  • 未接种疫苗情况下的血清阳性率在年轻成人和黑人成人中更高,反映这些群体观察到的较低疫苗接种率。

临床怎么用

  • NHANES 2021-2022结果可指导当前努力,以实现COVID-19基础免疫系列和加强针覆盖的疫苗公平。

局限性

  • CDC COVID-19监测系统使用商业实验室献血者数据的国家便利样本,这些系统数据的非随机抽样可能影响患病率估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CDC COVID-19 surveillance systems monitor SARS-CoV-2 antibody prevalence to collect information about asymptomatic, undiagnosed, and unreported disease using national convenience samples of blood donor data from commercial laboratories (1,2). However, nonrandom sampling of data from these systems could affect prevalence estimates (1-3). The National Health and Nutrition Examination Survey (NHANES) collects SARS-CoV-2 serology data among a sample of the general U.S. civilian population (4). In addition, NHANES collects self-reported COVID-19 vaccination and disease history, and its statistical sampling design is not based on health care access or blood donation. Therefore, NHANES data can be used to better quantify asymptomatic SARS-CoV-2 infection prevalence and seropositivity attained through infection without vaccination. Preliminary NHANES 2021-2022 results indicated that 41.6% of adults aged ≥18 years had serology indicative of past infection and that 43.7% of these adults, including 57.1% of non-Hispanic Black or African American (Black) adults, reported never having had COVID-19, possibly representing asymptomatic infection. In addition, 25.5% of adults whose serology indicated past infection reported never having received COVID-19 vaccination. Prevalences of seropositivity in the absence of vaccination were higher among younger adults and Black adults, reflecting the lower observed vaccination rates among these groups (5). These findings raise health equity concerns given the disparities observed in SARS-CoV-2 infection and COVID-19 vaccination. Results from NHANES 2021-2022 can guide ongoing efforts to achieve vaccine equity in COVID-19 primary vaccination series and booster dose coverage.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Akinbami LJ, Kruszon-Moran D, Wang CY, et al. SARS-CoV-2 Serology and Self-Reported Infection Among Adults - National Health and Nutrition Examination Survey, United States, August 2021-May 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36454698. doi:10.15585/mmwr.mm7148a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。